Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Share your knowledge and expertise with your regulatory peers by submitting an in-depth, evidence-based article focusing on key areas and emerging issues in the global regulatory landscape.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Registration is now open for RAPS Convergence 2021! Gather with the regulatory community 12-15 September for four days of learning, engagement, and excitement.
Keep the sparks coming! Delegates of the conference have access to on-demand content until the end of October 2021.
This updated edition is a great reference for anyone working in multinational product development and marketing.
Regipedia is an interactive resource created to benefit RAPS members with 24/7 access to more than 2,300 regulatory terms.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 11 July 2012 | By Alexander Gaffney, RAC
The European Medicines Agency (EMA) on Wednesday, 11 June released additional documents expanding the extent of its cooperation with the Pharmaceutical Inspection Co-Operation Scheme (PIC/S), first announced in December 2010.
PIC/S-composed of PIC and the PIC Scheme, which operate in tandem-works to promote inspection quality and cooperation among member counties, which include most European countries and, as of 2011, the US Food and Drug Administration (FDA). As of 2012, EMA is not a member of the PIC/S, though it is a "recognized partner."
The original agreement between the two organizations called for cooperating to advance the field of Good Manufacturing and Distribution Practice (GDMP) in order to share resources and avoid any duplication of efforts. In particular, the agency said it was interested in the exchange of information, including GDMP guidance documents developed by PIC/S and all legislation related to GDMP.
EMA sought to expand the 2010 agreement in May 2012 with an addendum, stating the two groups should work more on formal, rather than informal, harmonization procedures. "The GMP Guide and related documents should be harmonized between PIC/S and the GMDP Inspectors Working Group (IWG)," the addendum says, "although they need not be identical."
"To reach this goal, there should be an effective and co-operative exchange of information, including drafts and proposals, between both parties on all on-going revisions of existing documents or on the adoption of new documents, and this without delay," explained EMA and PIC/S.
To do this, both organizations will appoint liaison officers to regularly communicate with the other organization about "proposals influencing harmonized documents."
The more formalized approach to the harmonization of guidance documents will include the exchange of proposed and approved concept papers, participation in drafting groups, the exchange of draft documents, the opportunity for public and industry consultation, the preparation of a final draft, approval of final documents and the maintenance of finalized documents.
Read more:
Addendum to EMA-PIC/S's 2010 Agreement (May 2010)
EMA-PIC/S's 2010 Agreement
EMA's Landing Page for PIC/S Documents
2012 Confidentiality Agreement Signed by PIC/S
Tags: PIC Convention, PIC Scheme, GDMP, PIC/S, PIC, Harmonisation, GDP, harmonization, Latest News, GMP
Regulatory Focus newsletters
All the biggest regulatory news and happenings.